NVO logo

Novo Nordisk A/S (NVO) Total debt

Annual Total Debt:

$14.34B+$10.33B(+257.65%)
December 31, 2024

Summary

  • As of today (April 13, 2025), NVO annual total debt is $14.34 billion, with the most recent change of +$10.33 billion (+257.65%) on December 31, 2024.
  • During the last 3 years, NVO annual total debt has risen by +$10.28 billion (+253.53%).
  • NVO annual total debt is now at all-time high.

Performance

1-year change

+257.65%

3-year change

+253.53%

5-year change

+2033.69%

15-year change

+5153.17%

NVO Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.82%
NVO annual total debt is higher than 97.82% of companies in Healthcare sector

Range

All-time high

$14.34B
NVO annual total debt is currently at an all-time high

3-year low

$3.71B
NVO annual total debt is currently +286.43% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVO previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVO next annual earnings announcement has not yet been scheduled

OtherNVObalance sheet metrics

Annual Total Debt

$14.34B
NVO annual total debt is $14.34 billion

annual total liabilities

$44.97B
NVO annual total liabilities is $44.97 billion

annual total assets

$64.99B
NVO annual total assets is $64.99 billion

annual current assets

$22.45B
NVO annual total current assets is $22.45 billion

Quarterly Total Debt:

$14.34B+$5.81B(+68.05%)
December 31, 2024

Summary

  • As of today (April 13, 2025), NVO quarterly total debt is $14.34 billion, with the most recent change of +$5.81 billion (+68.05%) on December 31, 2024.
  • Over the past year, NVO quarterly total debt has stayed the same.
  • NVO quarterly total debt is now at all-time high.

Performance

3-month change

0%

1-year change

0%

3-year change

+253.53%

5-year change

+2033.69%

NVO Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

97.9%
NVO quarterly total debt is higher than 97.9% of companies in Healthcare sector

Range

All-time high

$14.34B
NVO quarterly total debt is currently at an all-time high

3-year low

$3.43B
NVO quarterly total debt is currently +317.80% above its 3-year low

Earnings dates

Last quarterly earnings report date

Dec 31, 2024
NVO previous earnings announcement was published on Dec 31, 2024

Next quarterly earnings report date

May 7, 2025
NVO next earnings announcement is scheduled for May 7, 2025

OtherNVObalance sheet metrics

quarterly total liabilities

$44.97B
NVO quarterly total liabilities is $44.97 billion

quarterly total assets

$64.99B
NVO quarterly total assets is $64.99 billion

quarterly current assets

$22.45B
NVO quarterly total current assets is $22.45 billion

quarterly current liabilities

$30.35B
NVO quarterly total current liabilities is $30.35 billion

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

Annual Total Debt

$14.34B
NVO annual total debt is $14.34 billion

Annual long term debt

$12.51B
NVO annual long term debt is $12.51 billion

Annual short term debt

$1.83B
NVO annual short term debt is $1.83 billion

NVO Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+257.6%0.0%
3 y3 years+253.5%+253.5%
5 y5 years+2033.7%+2033.7%

NVO Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+286.4%at high+317.8%
5 y5-yearat high+2033.7%at high+2262.6%
alltimeall timeat high>+9999.0%at high>+9999.0%

Novo Nordisk A/S Total debt History

DateAnnualQuarterly
Dec 2024
$14.34B(+257.7%)
$14.34B(+68.1%)
Sep 2024
-
$8.53B(+4.2%)
Jun 2024
-
$8.19B(+110.3%)
Mar 2024
-
$3.90B(-2.9%)
Dec 2023
$4.01B(+8.0%)
$4.01B(+6.7%)
Sep 2023
-
$3.76B(+0.2%)
Jun 2023
-
$3.75B(+0.4%)
Mar 2023
-
$3.74B(+0.7%)
Dec 2022
$3.71B(-8.5%)
$3.71B(+8.1%)
Sep 2022
-
$3.43B(-3.9%)
Jun 2022
-
$3.57B(-6.6%)
Mar 2022
-
$3.82B(-5.7%)
Dec 2021
$4.06B(+137.0%)
$4.06B(+89.1%)
Sep 2021
-
$2.14B(-2.6%)
Jun 2021
-
$2.20B(+44.7%)
Mar 2021
-
$1.52B(-11.1%)
Dec 2020
$1.71B(+154.7%)
$1.71B(+164.5%)
Sep 2020
-
$647.09M(+3.5%)
Jun 2020
-
$624.99M(+3.0%)
Mar 2020
-
$606.99M(-9.7%)
Dec 2019
$672.10M(+751.9%)
$672.10M(+5.6%)
Sep 2019
-
$636.42M(-1.3%)
Jun 2019
-
$644.72M(-0.6%)
Mar 2019
-
$648.91M(+722.5%)
Dec 2018
$78.89M(-71.1%)
$78.89M(+50.5%)
Sep 2018
-
$52.43M(+36.9%)
Jun 2018
-
$38.31M(+1.6%)
Mar 2018
-
$37.69M(-86.2%)
Dec 2017
$272.99M(+738.3%)
$272.99M(+563.4%)
Sep 2017
-
$41.15M(-84.1%)
Jun 2017
-
$258.90M(+194.0%)
Mar 2017
-
$88.06M(+170.4%)
Dec 2016
$32.57M(-79.3%)
$32.57M(-52.5%)
Sep 2016
-
$68.63M(+13.1%)
Jun 2016
-
$60.71M(-1.7%)
Mar 2016
-
$61.73M(-60.7%)
Dec 2015
$157.17M(+33.7%)
$157.17M(+65.4%)
Sep 2015
-
$95.03M(-14.1%)
Jun 2015
-
$110.64M(+28.5%)
Mar 2015
-
$86.11M(-26.7%)
Dec 2014
$117.55M(+195.4%)
$117.55M(+142.8%)
Sep 2014
-
$48.41M(-34.8%)
Jun 2014
-
$74.28M(-49.8%)
Mar 2014
-
$148.04M(+272.0%)
Dec 2013
$39.79M(-55.1%)
$39.79M(-67.2%)
Sep 2013
-
$121.22M(-3.1%)
Jun 2013
-
$125.11M(+142.6%)
Mar 2013
-
$51.56M(-41.8%)
Dec 2012
$88.62M(-40.4%)
$88.62M(-53.1%)
Sep 2012
-
$188.91M(+26.8%)
Jun 2012
-
$148.95M(-6.9%)
Mar 2012
-
$159.98M(+7.6%)
Dec 2011
$148.64M(-62.5%)
$148.64M(-62.9%)
Sep 2011
-
$400.43M(+48.6%)
Jun 2011
-
$269.55M(-5.8%)
Mar 2011
-
$286.21M(-27.9%)
Dec 2010
$396.74M(+48.6%)
$396.74M(+8.7%)
Sep 2010
-
$364.87M(-48.1%)
Jun 2010
-
$703.55M(+93.5%)
Mar 2010
-
$363.53M(+36.2%)
Dec 2009
$266.97M(-38.7%)
$266.97M(+13.8%)
Sep 2009
-
$234.53M(-13.1%)
Jun 2009
-
$269.90M(-38.3%)
Mar 2009
-
$437.49M(+0.4%)
Dec 2008
$435.66M(+63.2%)
$435.66M(+29.6%)
Sep 2008
-
$336.08M(+14.2%)
Jun 2008
-
$294.17M(-10.1%)
Mar 2008
-
$327.10M(+22.5%)
Dec 2007
$267.02M(-0.3%)
$267.02M(+8.6%)
Sep 2007
-
$245.86M(+7.4%)
Jun 2007
-
$229.00M(-6.5%)
Mar 2007
-
$245.00M(-8.5%)
Dec 2006
$267.85M(-37.3%)
$267.85M(+6.3%)
Sep 2006
-
$252.00M(-2.2%)
Jun 2006
-
$257.78M(-33.7%)
Mar 2006
-
$388.57M(-9.0%)
Dec 2005
$427.00M(+37.4%)
$427.00M(+24.6%)
Sep 2005
-
$342.81M(+13.3%)
Jun 2005
-
$302.57M(+3.9%)
Mar 2005
-
$291.16M(-6.3%)
Dec 2004
$310.69M
$310.69M(+56.9%)
Sep 2004
-
$198.05M(-0.4%)
DateAnnualQuarterly
Jun 2004
-
$198.78M(-22.9%)
Mar 2004
-
$257.83M(-12.0%)
Dec 2003
$293.01M(+49.6%)
$293.01M(>+9900.0%)
Sep 2003
-
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
Mar 2003
-
$0.00(-100.0%)
Dec 2002
$195.83M(-2.1%)
$195.83M(>+9900.0%)
Sep 2002
-
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
Mar 2002
-
$0.00(-100.0%)
Dec 2001
$199.99M(-9.1%)
$199.99M(>+9900.0%)
Sep 2001
-
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
Mar 2001
-
$0.00(-100.0%)
Dec 2000
$220.02M(-18.6%)
$220.02M(>+9900.0%)
Sep 2000
-
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
Dec 1999
$270.41M(-37.4%)
$270.41M(>+9900.0%)
Sep 1999
-
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
Mar 1999
-
$0.00(-100.0%)
Dec 1998
$431.97M(-5.1%)
$431.97M(>+9900.0%)
Sep 1998
-
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
Mar 1998
-
$0.00(-100.0%)
Dec 1997
$455.16M(+17.7%)
$455.16M(>+9900.0%)
Sep 1997
-
$0.00(0.0%)
Jun 1997
-
$0.00(0.0%)
Mar 1997
-
$0.00(-100.0%)
Dec 1996
$386.59M(+4.9%)
$386.59M(>+9900.0%)
Sep 1996
-
$0.00(0.0%)
Jun 1996
-
$0.00(0.0%)
Mar 1996
-
$0.00(-100.0%)
Dec 1995
$368.70M(-50.8%)
$368.70M(>+9900.0%)
Sep 1995
-
$0.00(0.0%)
Jun 1995
-
$0.00(0.0%)
Mar 1995
-
$0.00(-100.0%)
Dec 1994
$750.04M(+18.0%)
$750.04M(>+9900.0%)
Sep 1994
-
$0.00(0.0%)
Jun 1994
-
$0.00(0.0%)
Mar 1994
-
$0.00(-100.0%)
Dec 1993
$635.74M(+11.0%)
$635.74M(>+9900.0%)
Sep 1993
-
$0.00(0.0%)
Jun 1993
-
$0.00(0.0%)
Mar 1993
-
$0.00(-100.0%)
Dec 1992
$572.85M(+10.3%)
$572.85M(>+9900.0%)
Sep 1992
-
$0.00(0.0%)
Jun 1992
-
$0.00(0.0%)
Mar 1992
-
$0.00(-100.0%)
Dec 1991
$519.31M(+5.0%)
$519.31M(>+9900.0%)
Sep 1991
-
$0.00(0.0%)
Jun 1991
-
$0.00(0.0%)
Mar 1991
-
$0.00(-100.0%)
Dec 1990
$494.69M(-3.0%)
$494.69M(>+9900.0%)
Sep 1990
-
$0.00(0.0%)
Jun 1990
-
$0.00(0.0%)
Mar 1990
-
$0.00(-100.0%)
Dec 1989
$510.00M(+67.0%)
$510.00M(>+9900.0%)
Sep 1989
-
$0.00(0.0%)
Jun 1989
-
$0.00(0.0%)
Mar 1989
-
$0.00(-100.0%)
Dec 1988
$305.36M(-3.2%)
$305.36M(>+9900.0%)
Sep 1988
-
$0.00(0.0%)
Jun 1988
-
$0.00(0.0%)
Mar 1988
-
$0.00(-100.0%)
Dec 1987
$315.48M(+136.0%)
$315.48M(>+9900.0%)
Sep 1987
-
$0.00(0.0%)
Jun 1987
-
$0.00(0.0%)
Mar 1987
-
$0.00(-100.0%)
Dec 1986
$133.66M(+49.8%)
$133.66M(>+9900.0%)
Sep 1986
-
$0.00(0.0%)
Jun 1986
-
$0.00(0.0%)
Mar 1986
-
$0.00(-100.0%)
Dec 1985
$89.24M(-34.8%)
$89.24M(>+9900.0%)
Sep 1985
-
$0.00(0.0%)
Jun 1985
-
$0.00(0.0%)
Mar 1985
-
$0.00(-100.0%)
Dec 1984
$136.84M
$136.84M(>+9900.0%)
Sep 1984
-
$0.00(0.0%)
Jun 1984
-
$0.00(0.0%)
Mar 1984
-
$0.00

FAQ

  • What is Novo Nordisk A/S annual total debt?
  • What is the all time high annual total debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual total debt year-on-year change?
  • What is Novo Nordisk A/S quarterly total debt?
  • What is the all time high quarterly total debt for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly total debt year-on-year change?

What is Novo Nordisk A/S annual total debt?

The current annual total debt of NVO is $14.34B

What is the all time high annual total debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total debt is $14.34B

What is Novo Nordisk A/S annual total debt year-on-year change?

Over the past year, NVO annual total debt has changed by +$10.33B (+257.65%)

What is Novo Nordisk A/S quarterly total debt?

The current quarterly total debt of NVO is $14.34B

What is the all time high quarterly total debt for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total debt is $14.34B

What is Novo Nordisk A/S quarterly total debt year-on-year change?

Over the past year, NVO quarterly total debt has changed by $0.00 (0.00%)
On this page